[HTML] lww.com

[HTML][HTML] CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?

C Vitale, V Griggio, F Perutelli, M Coscia - HemaSphere, 2023 - journals.lww.com
The clinical development of chimeric antigen receptor (CAR) T-cell therapy has been more
challenging for chronic lymphocytic leukemia (CLL) compared to other settings. One of the …
被引用次数：3 相关文章

CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?

C Vitale, V Griggio, F Perutelli, M Coscia - Hemasphere, 2023 - europepmc.org
The clinical development of chimeric antigen receptor (CAR) T-cell therapy has been more
challenging for chronic lymphocytic leukemia (CLL) compared to other settings. One of the …

CAR‐modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?

C Vitale, V Griggio, F Perutelli, M Coscia - HemaSphere, 2023 - Wiley Online Library
The clinical development of chimeric antigen receptor (CAR) T‐cell therapy has been more
challenging for chronic lymphocytic leukemia (CLL) compared to other settings. One of the …
[HTML] lww.com

[HTML][HTML] CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?

C Vitale, V Griggio, F Perutelli, M Coscia - HemaSphere, 2023 - journals.lww.com
The clinical development of chimeric antigen receptor (CAR) T-cell therapy has been more
challenging for chronic lymphocytic leukemia (CLL) compared to other settings. One of the …

CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?

C Vitale, V Griggio, F Perutelli, M Coscia - HemaSphere, 2023 - pubmed.ncbi.nlm.nih.gov
The clinical development of chimeric antigen receptor (CAR) T-cell therapy has been more
challenging for chronic lymphocytic leukemia (CLL) compared to other settings. One of the …

CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?

C Vitale, V Griggio, F Perutelli, M Coscia - HEMASPHERE, 2023 - iris.unito.it
The clinical development of chimeric antigen receptor (CAR) T-cell therapy has been more
challenging for chronic lymphocytic leukemia (CLL) compared to other settings. One of the …
[HTML] nih.gov

[HTML][HTML] CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?

C Vitale, V Griggio, F Perutelli, M Coscia - HemaSphere, 2023 - ncbi.nlm.nih.gov
The clinical development of chimeric antigen receptor (CAR) T-cell therapy has been more
challenging for chronic lymphocytic leukemia (CLL) compared to other settings. One of the …

CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?

C Vitale, V Griggio, F Perutelli, M Coscia - Hemasphere, 2023 - europepmc.org
The clinical development of chimeric antigen receptor (CAR) T-cell therapy has been more
challenging for chronic lymphocytic leukemia (CLL) compared to other settings. One of the …